Michigan Medicine releases a new study on the link between high-risk blood clot formation and COVID-19. Higher levels of suPAR, a protein that circulates in the blood and originates from immune cells, were associated with an increased risk of blood clot formation in patients hospitalized with COVID-19. Salim Hayek, M.D., medical director of the U-M Frankel Cardiovascular Center Clinics, shares insights from his work with a team of researchers from across the globe and implications for future treatments.
Free Stadium Blanket. Join for Life.